About
Technology
Issues
FAQ
Links
Official Page
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.